Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
38 | 4819 | 48.7 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1174 | 8976 | NON ALCOHOLIC FATTY LIVER DISEASE//NON ALCOHOLIC STEATOHEPATITIS//TRANSIENT ELASTOGRAPHY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NON ALCOHOLIC FATTY LIVER DISEASE | Author keyword | 914 | 53% | 25% | 1199 |
2 | NON ALCOHOLIC STEATOHEPATITIS | Author keyword | 603 | 57% | 15% | 722 |
3 | NASH | Author keyword | 223 | 53% | 6% | 293 |
4 | NAFLD | Author keyword | 172 | 41% | 7% | 326 |
5 | FATTY LIVER | Author keyword | 148 | 28% | 10% | 460 |
6 | STEATOHEPATITIS | Author keyword | 140 | 46% | 5% | 226 |
7 | STEATOSIS | Author keyword | 70 | 22% | 6% | 281 |
8 | CONTROLLED ATTENUATION PARAMETER | Author keyword | 45 | 90% | 0% | 19 |
9 | HEPATIC STEATOSIS | Author keyword | 42 | 22% | 3% | 167 |
10 | NONALCOHOLIC STEATOHEPATITIS NASH | Author keyword | 42 | 67% | 1% | 38 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NON ALCOHOLIC FATTY LIVER DISEASE | 914 | 53% | 25% | 1199 | Search NON+ALCOHOLIC+FATTY+LIVER+DISEASE | Search NON+ALCOHOLIC+FATTY+LIVER+DISEASE |
2 | NON ALCOHOLIC STEATOHEPATITIS | 603 | 57% | 15% | 722 | Search NON+ALCOHOLIC+STEATOHEPATITIS | Search NON+ALCOHOLIC+STEATOHEPATITIS |
3 | NASH | 223 | 53% | 6% | 293 | Search NASH | Search NASH |
4 | NAFLD | 172 | 41% | 7% | 326 | Search NAFLD | Search NAFLD |
5 | FATTY LIVER | 148 | 28% | 10% | 460 | Search FATTY+LIVER | Search FATTY+LIVER |
6 | STEATOHEPATITIS | 140 | 46% | 5% | 226 | Search STEATOHEPATITIS | Search STEATOHEPATITIS |
7 | STEATOSIS | 70 | 22% | 6% | 281 | Search STEATOSIS | Search STEATOSIS |
8 | CONTROLLED ATTENUATION PARAMETER | 45 | 90% | 0% | 19 | Search CONTROLLED+ATTENUATION+PARAMETER | Search CONTROLLED+ATTENUATION+PARAMETER |
9 | HEPATIC STEATOSIS | 42 | 22% | 3% | 167 | Search HEPATIC+STEATOSIS | Search HEPATIC+STEATOSIS |
10 | NONALCOHOLIC STEATOHEPATITIS NASH | 42 | 67% | 1% | 38 | Search NONALCOHOLIC+STEATOHEPATITIS+NASH | Search NONALCOHOLIC+STEATOHEPATITIS+NASH |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STEATOHEPATITIS | 860 | 49% | 26% | 1264 |
2 | CRYPTOGENIC CIRRHOSIS | 439 | 73% | 7% | 337 |
3 | HEPATIC STEATOSIS | 381 | 33% | 20% | 950 |
4 | FATTY LIVER DISEASE | 305 | 26% | 21% | 1006 |
5 | NON ALCOHOLIC STEATOHEPATITIS | 262 | 26% | 18% | 864 |
6 | NAFLD | 162 | 61% | 4% | 174 |
7 | NONALCOHOLIC FATTY LIVER | 146 | 35% | 7% | 345 |
8 | STEATOSIS | 127 | 23% | 10% | 477 |
9 | STEATOHEPATITIS NASH | 103 | 91% | 1% | 42 |
10 | NASH | 78 | 43% | 3% | 136 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | 2012 | 428 | 174 | 82% |
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | 2011 | 447 | 109 | 84% |
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis | 2013 | 105 | 208 | 77% |
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease | 2010 | 410 | 68 | 74% |
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease | 2014 | 33 | 106 | 69% |
Nonalcoholic fatty liver disease: From steatosis to cirrhosis | 2006 | 851 | 125 | 83% |
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments | 2014 | 32 | 108 | 68% |
A concise review of non-alcoholic fatty liver disease | 2015 | 8 | 122 | 61% |
Human Fatty Liver Disease: Old Questions and New Insights | 2011 | 448 | 46 | 41% |
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis | 2014 | 22 | 71 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STORR LIVER UNIT | 11 | 18% | 1.2% | 56 |
2 | LIVER IMAGING GRP | 11 | 42% | 0.4% | 20 |
3 | STUDY GENOM LIVER DIS | 9 | 48% | 0.3% | 14 |
4 | AUDIE L MURPHY VET ADM MED | 9 | 83% | 0.1% | 5 |
5 | NAFLD TRANSLAT UNIT | 8 | 70% | 0.1% | 7 |
6 | BETTY GUY BEATTY INTEGRATED | 8 | 29% | 0.5% | 24 |
7 | UNIT METAB AUTOIMMUNE LIVER DIS | 6 | 80% | 0.1% | 4 |
8 | UNIT METAB DIS CLIN DIETET | 6 | 37% | 0.3% | 14 |
9 | HEPATOMETAB DIS UNIT | 6 | 41% | 0.2% | 12 |
10 | INTERNAL MED METAB 3 | 6 | 71% | 0.1% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000265131 | ADIPONUTRIN//PNPLA3//PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 |
2 | 0.0000144107 | GAMMA GLUTAMYL TRANSFERASE//GAMMA GLUTAMYLTRANSFERASE FRACTIONS//GAMMA GLUTAMYLTRANSFERASE ACTIVITY |
3 | 0.0000090076 | STEATOSIS//HEPATOGENOUS DIABETES//DIPARTIMENTO MED GASTROENTEROL ALMA MATER STUDI |
4 | 0.0000077564 | WATER FAT SEPARATION//FAT SUPPRESSION//FAT QUANTIFICATION |
5 | 0.0000059506 | TRANSIENT ELASTOGRAPHY//LIVER STIFFNESS//FIBROSCAN |
6 | 0.0000056048 | ORNITHINE CARBAMYLTRANSFERASE//CLIN CARDIOLPOST COURSE//GPT2 |
7 | 0.0000052763 | M65//M30//M65 ELISA |
8 | 0.0000046285 | FULMINANT TYPE 1 DIABETES//HEPATIC GLYCOGENOSIS//MAURIAC SYNDROME |
9 | 0.0000045322 | PUBL HLTH SCI MED STAT GRP//PULSE FUNCTIONS//ULCH UCL NIHR BIOMED |
10 | 0.0000042382 | HS OS 1//BRM BIOLOGICAL RESPONSE MODIFIER//DIAGNOST RADIOL RADIAT ONCOL |